A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Engineering anthracycline biosynthesis toward angucyclines




TekijätMetsa-Ketela M, Palmu K, Kunnari T, Ylihonko K, Mantsala P

KustantajaAMER SOC MICROBIOLOGY

Julkaisuvuosi2003

Lehti:Antimicrobial Agents and Chemotherapy

Tietokannassa oleva lehden nimiANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lehden akronyymiANTIMICROB AGENTS CH

Vuosikerta47

Numero4

Aloitussivu1291

Lopetussivu1296

Sivujen määrä6

ISSN0066-4804

DOIhttps://doi.org/10.1128/AAC.47.4.1291-1296.2003


Tiivistelmä
The biosynthesis pathways of two anthracyclines, nogalamycin and aclacinomycin, were directed toward angucyclines by using an angucycline-specific cyclase, pgaF, isolated from a silent antibiotic biosynthesis gene cluster. Addition of pgaF to a gene cassette that harbored the early biosynthesis genes of nogalamycin resulted in the production of two known angucyclinone metabolites, rabelomycin and its precursor, UWM6. Substrate flexibility of pgaF was demonstrated by replacement of the nogalamycin minimal polyketide synthase genes in the gene cassette with the equivalent aclacinomycin genes together with aknE2 and aknF, which specify the unusual propionate starter unit in aclacinomycin biosynthesis. This modification led to the production of a novel angucyclinone, MM2002, in which the expected ethyl side chain was incorporated into the fourth ring.



Last updated on 2025-14-10 at 09:43